Sotorasib
| CAS No. | 2296729-00-3 |
|---|---|
| MDL No. | N/A |
| MF | C30H30F2N6O3 |
| MW | 560.60 |
| InChI Key | NXQKSXLFSAEQCZ-SFHVURJKSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Sotorasib is a pyridopyrimidine with substituents at positions 1, 4, 6, and 7: 4-methyl-2-(propan-2-yl)pyridin-3-yl, (2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl, fluoro, and 2-fluoro-6-hydroxyphenyl groups. It is approved for treating non-small cell lung cancer with KRAS(G12C) mutations and functions as an antineoplastic agent. It belongs to acrylamides, N-acylpiperazines, pyridopyrimidines, monofluorobenzenes, methylpyridines, tertiary carboxamides, tertiary amino compounds, and phenols.
| CAS No. | 2296729-00-3 |
|---|---|
| Product Name | Sotorasib |
| Heavy Atom Count | 41 | Rotatable Bond Count | 5 |
| Atom Stereo Count | 1 | Bond Stereo Count | 0 |
| HBA | 8 | HBD | 1 |
| TPSA | 104.450 Ų | Charge | 0 |
| Exact Mass | 560.23475 | Complexity | 1732.75 |
| pKa | 6.550 | XLogP | 4.481 |
